UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

October 25, 2017

(Exact name of registrant as specified in its charter)

Delaware	001-33829	98-0517725
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)

5301 Legacy Drive, Plano, Texas 75024

(Address of principal executive offices, including zip code)

(972) 673-7000

(Registrant’s telephone number including area code)

Not Applicable

(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Item 2.02 Results of Operations and Financial Condition.

On October 25, 2017, Dr Pepper Snapple Group, Inc. (the "Company") issued a press release announcing its financial results for the third quarter of its fiscal year ended September 30, 2017. A copy of such press release is attached as Exhibit 99.1 and will be published on the Company’s web site at http://www.drpeppersnapple.com. The press release includes certain non-generally accepted accounting principles ("non-GAAP") financial measures. Reconciliations to the most directly comparable generally accepted accounting principles ("GAAP") financial measures are included in the press release.

On October 25, 2017, the Company will hold a telephone conference and webcast to discuss the Company’s financial results for the third quarter of its fiscal year ended September 30, 2017. During this conference, the Company will present certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures and supplementary information related to these reconciliations will be posted to the Company’s website at http://www.drpeppersnapple.com prior to the start of the call.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT
NUMBER	DESCRIPTION
99.1	Dr Pepper Snapple Group, Inc. Press Release dated October 25, 2017 — ''Dr Pepper Snapple Group Reports Third Quarter 2017 Results''.

Pursuant to the rules and regulations of the Securities and Exchange Commission, the information in this Current Report on Form 8-K, including the press release attached as Exhibit 99.1, is deemed to be furnished and shall not be deemed to be "filed" under the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	DR PEPPER SNAPPLE GROUP, INC.
Date: October 25, 2017
	By:	/s/ James L. Baldwin
		Name:	James L. Baldwin
		Title:	Executive Vice President, General Counsel & Secretary

EXHIBIT INDEX

Exhibit
Number	Description
99.1	Dr Pepper Snapple Group, Inc. Press Release dated October 25, 2017 — ''Dr Pepper Snapple Group Reports Third Quarter 2017 Results''.